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Abstract We sought to determine the e¡ects of the superoxide
dismutase (SOD) inhibitor diethyldithiocarbamate (DETC) on
vascular superoxide production. Rat aortic rings treated with
DETC (10 mM) showed no change of superoxide generation
(5 WM lucigenin). Likewise, DETC did not change the expres-
sion and activity of vascular soluble guanylyl cyclase, an enzyme
known to be extremely sensitive to superoxide. In striking con-
trast, DETC completely inhibited the superoxide production
induced by 6-anilino-5,8-quinolinedione (LY83583) and abol-
ished the catalytic activity of xanthine oxidase (XO). Thus,
DETC inhibits vascular superoxide production by blocking oxi-
doreductase enzymes such as XO and those reducing LY83583
in rat aorta.
4 2003 Published by Elsevier B.V. on behalf of the Federation
of European Biochemical Societies.
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1. Introduction
Vascular oxidative stress has been shown to contribute to a
variety of cardiovascular diseases such as coronary artery dis-
ease, heart failure, diabetes and hypertension. The mechanism
underlying increased bioavailability of vascular reactive oxy-
gen species is multifactorial and involves increased expression
and activity of enzymes generating oxygen radicals such as
reduced nicotinamide adenine dinucleotide phosphate
(NADPH) oxidase, a decreased expression and activity of
enzymes which detoxify reactive oxygen species such as super-
oxide dismutases (SODs) and a decreased concentration of
typical cellular antioxidants such as cysteine and glutathione
[1,2]. These mechanisms are currently investigated in many
research laboratories by the use of low molecular activators
and inhibitors of enzymes which either produce or detoxify
reactive oxygen species.
Diethyldithiocarbamate (DETC) is a metal ion-chelating
agent which is a well-known inhibitor of SODs [3]. In addi-
tion, DETC has been described as an inhibitor of nuclear
factor (NF) UB and it was found that DETC is able to trap
nitric oxide (NO) [4,5]. These activities should result in an
increase of vascular superoxide production in tissues including
the vasculature. Indeed, the results of previous investigations
in atherosclerotic rabbit aorta indicate that this seems to be
the case [6,7]. In an attempt to investigate the e¡ects of DETC
on vascular superoxide production stimulated with 6-anilino-
5,8-quinolinedione (LY83583), a quinone derivative known to
generate superoxide intracellularly [8], we did not ¢nd a fur-
ther increase but an almost complete inhibition of the stimu-
lated superoxide generation. Thus, we sought to determine if
DETC signi¢cantly impacts on oxidoreductases in the vascu-
lature.
2. Materials and methods
2.1. Preparation and incubation of isolated thoracic aorta
We investigated isolated thoracic aortic rings of 21 normal male
Wistar rats (WIS) at an age of 3^4 months. Aortas were excised after
removal of the hearts and rapidly immersed in Krebs^HEPES bu¡er
(pH 7.4) of the following composition (in g/l) : NaCl, 5.782; KCl,
0.350; CaCl2, 0.275; MgSO4, 0.296; NaHCO3, 2.1; K2HPO4, 0.14;
Na^HEPES, 5.206; D-glucose, 2.0. Two segments of each aorta were
used. Segments were subjected to vehicle, LY83583 (10 WM) and
DETC (10 mM) for 4 h in Krebs^HEPES bu¡er in a water jacketed
organ bath (37‡C). The drugs were renewed every 30 min. The seg-
ments were subsequently frozen in liquid nitrogen.
2.2. Preparation of 100 000Ug supernatants
Frozen segments were homogenized in 2 ml Tris bu¡er (5 mmol/l)
supplemented with dithiothreitol (DTT) (5 mmol/l) and the proteinase
inhibitors leupeptin, benzamidine, aprotinin, phenylmethylsulfonyl
£uoride (PMSF) and antipain (10 Wg/ml). The homogenate was cen-
trifuged at 4‡C at 100Ug (10 min), 10 000Ug (15 min), and
100 000Ug (1 h). The obtained cytosolic fraction was stored in ali-
quots at 380‡C and used for enzyme activity assays and Western
blotting. Protein content was measured by the method of Bradford
[9] using bovine serum albumin (BSA) as a standard.
2.3. Western blotting
Western blotting was performed as described previously [10].
Brie£y, each lane was loaded with 10 Wg total protein, and blots
were incubated with a soluble guanylyl cyclase (sGC) antibody stain-
ing the b1 subunit of sGC (sGC-b1, Alexis). After incubation with a
peroxidase A-conjugated antirabbit IgG (Calbiochem, Darmstadt,
Germany), blots were developed using enhanced chemiluminescence
(ECL) (Roche) and exposed to X-ray ¢lms.
2.4. Determination of sGC activity
Speci¢c activity of sGC was measured by the formation of [32P]-
cyclic guanosine monophosphate (cGMP) from [K-32P]guanosine tri-
phosphate (GTP), as described previously [11]. Brie£y, sGC of aortic
cytosols (20^40 Wg of protein) was incubated in a total volume of
100 Wl of a triethanolamine^HCl bu¡er (50 mM, pH 7.4, 37‡C) con-
taining [K-32P]GTP (5 nM, 0.4 WCi), GTP (100 Wmol/l), cGMP
(1 mmol/l), 3-isobutyl-1-methylxanthine (IBMX, 1 mmol/l), MgCl2
0014-5793 / 03 / $22.00 M 2003 Published by Elsevier B.V. on behalf of the Federation of European Biochemical Societies.
doi:10.1016/S0014-5793(03)00876-7
*Corresponding author. Fax: (49)-211-81 14781.
E-mail address: kojda@uni-duesseldorf.de (G. Kojda).
Abbreviations: DETC, diethyldithiocarbamate; DMSO, dimethylsulf-
oxide; DTT, dithiothreitol; LY83583, 6-anilino-5,8-quinolinedione;
sGC, soluble guanylyl cyclase; SNAP, S-nitroso-N-acetylpenicill-
amine; SOD, superoxide dismutase; XO, xanthine oxidase; X/XO,
xanthine/xanthine oxidase
FEBS 27575 27-8-03
FEBS 27575 FEBS Letters 551 (2003) 99^103
(1 mmol/l) and DTT (1 mmol/l) in the presence of racemic S-nitroso-
N-acetylpenicillamine (SNAP) (1 Wmol to 1 mmol/l) or vehicle (max-
imal 0.25% dimethylsulfoxide (DMSO)).
2.5. Quanti¢cation of superoxide production
Generation of superoxide radicals by thoracic aorta of the rat was
measured by use of the lucigenin assay as described previously [12].
Brie£y, aortic rings (5 mm width) were equilibrated in Krebs^HEPES
bu¡er (pH 7.4, 37‡C) with vehicle, LY83583 (10 WM) or DETC
(10 mM) for 30 min and then transferred to vials containing albumin
bu¡er enriched with 5 WM lucigenin (pH 7.4, 37‡C). Superoxide pro-
duction in the vessel segments was detected by measuring the lumin-
ometer counts cumulatively over 20 min. These data were corrected
for background counts. Generation of superoxide was achieved by
adding xanthine oxidase (XO) (1 mU/ml) to increasing concentrations
of xanthine (0.1^2.4 WM) dissolved in albumin bu¡er [12] with vehicle
or DETC (10 mM). In another series of experiments the superoxide-
induced oxidation of adrenaline to adrenochrome was monitored as
described previously [13]. Brie£y, 25 mU/ml XO and 50 WM xanthine
or 10^20 Wl of a saturated KO2 solution in dry DMSO were added to
2 mM adrenaline dissolved in 50 mM phosphate bu¡er (pH 7.6, 25‡C)
and formation of adrenochrome was monitored at 480 nm in the
presence of 1 WM to 10 mM DETC, 10 Wg/ml SOD, 10 Wg/ml
SOD+1 mM DETC or vehicle.
2.6. Substances and solutions
Racemic SNAP was synthesized as described previously [14]. The
stock solution of SNAP (10 mM) was prepared daily in DMSO (5%),
kept on ice and protected from daylight. Grade I XO from buttermilk
and bovine erythrocyte SOD were obtained from Sigma. All other
chemicals were obtained from Merck, Darmstadt, Germany or from
Sigma, Deisenhofen, Germany, in analytical grade. All concentrations
indicated in the text, ¢gures and tables are expressed as ¢nal bath
concentrations.
2.7. Statistics
All data were analyzed by standard computer programs (GraphPad
Prism PC Software version 3.0, analysis of variance (ANOVA)) and
are expressed as mean values and standard error of the mean
(S.E.M.). Signi¢cant di¡erences were evaluated using either New-
man^Keuls multiple comparison test (ANOVA) or two-way ANOVA.
P6 0.05 was considered signi¢cant.
3. Results
3.1. E¡ect of DETC and LY83583 on aortic superoxide
generation
Suprisingly, the SOD inhibitor DETC had no e¡ect on
aortic superoxide generation (Fig. 1A), while LY83583
strongly increased the lucigenin chemiluminescence signals
(Fig. 1B). After 20 min the rate of superoxide generation
was increased from 78S 3.8 counts/mg (vehicle) to 147S 18.4
counts/mg (LY83583, P=0.0043). This increase of superoxide
generation was completely inhibited by DETC (Fig. 1C). The
superoxide generation measured in the presence of LY83583
and DETC (59S14.6 counts/mg) was identical to control val-
ues (65 S 12.2 counts/mg, Ps 0.05).
3.2. E¡ect of DETC on XO-induced superoxide generation
To evaluate an interference of DETC with superoxide de-
tection by lucigenin, we ¢rst monitored generation of super-
oxide by xanthine/XO (X/XO) with and without DETC. In-
creasing concentrations of xanthine correlated with the rate of
superoxide production (Fig. 2A) reaching a maximum value
of 9861S 937 counts at 2.4 WM xanthine. This was almost
completely abolished by DETC (Fig. 2B).
3.3. E¡ect of DETC on oxidation of adrenaline by X/XO
To con¢rm the inhibition of XO by DETC, we monitored
the oxidation of adrenaline by di¡erent concentrations of
KO2 and found no e¡ect of 1 mM DETC (Fig. 3A), while
the inhibitory e¡ect of SOD on adrenochrome formation was
almost blunted by DETC suggesting that DETC inhibits SOD
Fig. 1. Bioavailability of superoxide in rat aortic rings preincubated
with 10 mM DETC (A), 10 WM LY83583 (B) and 10 mM DETC
plus 10 WM LY83583 (C). Superoxide was measured by lucigenin
chemiluminescence. Each point represents the mean (S S.E.M., oc-
casionally smaller than symbols) of three di¡erent experiments using
three di¡erent rats (*P6 0.01, ANOVA).
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activity. Furthermore, DETC concentration dependently in-
hibited adrenochrome formation induced by X/XO (Fig. 3C
and D). These data indicate that 1 mM DETC, a concentra-
tion often used to inhibit SODs, can completely inhibit the
catalytic activity of XO.
3.4. E¡ect of DETC and LY83583 on vascular sGC activity
Changes of NO-stimulated sGC activity were used to mea-
sure consequences of increased superoxide in aortic rings
treated with DETC and LY83583. Contrary to DETC,
LY83583 strongly decreased the SNAP-dependent activation
of sGC (Fig. 4). These results indicate that superoxide
strongly inhibits sGC activity. In addition, these data con¢rm
that DETC does not increase vascular superoxide generation.
3.5. E¡ect of DETC and LY83583 on vascular sGC expression
The LY83583-induced decrease of sGC activity might be
explained by a reduction of sGC expression. However, West-
ern blot analysis showed that LY83583 induced a signi¢cant
increase of sGC expression (Fig. 5) suggesting that inhibition
of sGC activity by intracellular superoxide induces a compen-
satory increase of enzyme expression. Again DETC had no
e¡ect which further con¢rms that DETC does not increase
vascular superoxide production in rat aorta.
4. Discussion
We investigated the e¡ects of DETC, a well-known inhib-
itor of SOD, on vascular superoxide production. Our new
¢nding is that DETC can completely inhibit the catalytic ac-
tivity of vascular XO. Furthermore, DETC did not a¡ect
basal vascular superoxide production but abolished the
LY83583-induced increase of superoxide. Cellular e¡ects in-
duced by increased vascular superoxide production such as a
reduced expression and activity of sGC were not initiated by
DETC. These data suggest that DETC inhibits oxidoreduc-
tase enzymes such as XO and those reducing LY83583 in rat
aorta.
DETC is a metal ion-chelating agent which is known as an
e¡ective inhibitor of SODs [3]. Other known actions of DETC
include the inhibition of NFUB and its ability to trap NO
[4,5]. Here we report that DETC is also an inhibitor of vas-
cular XO. In experiments with rat aortic rings, DETC did not
increase vascular superoxide. Furthermore, DETC completely
abolished the increase of vascular superoxide induced by
treatment with LY83583. There are many di¡erent mecha-
nisms which might explain this unexpected activity of
DETC. Among these, inhibition of superoxide generation
from LY83583 and a scavenger e¡ect for readily generated
superoxide seem to be particularly interesting.
Monitoring lucigenin signals during incubation of XO with
increasing concentrations of xanthine showed a strong inhib-
itory activity of DETC. Further experiments demonstrated a
concentration-dependent inhibition of the X/XO-induced oxi-
dation of adrenaline to adrenochrome by DETC, while the
oxidation induced by KO2 was not a¡ected. These data
strongly indicate that DETC inhibits the catalytic activity of
XO. However, it is rather unlikely that this enzyme, which
introduces oxygen residues, contributes to the enzymatic re-
duction of LY83583 in intact aortic rings. In general, it is
assumed that the semiquinone radical resulting from a one-
electron reduction of LY83583 transfers its electron to molec-
ular oxygen and induces superoxide formation. Indeed, prior
reports demonstrated that LY83583 can be processed by dif-
ferent NADPH-dependent enzymes. For example, Kumagai et
al. reported the generation of superoxide from LY83583, as
detected by electron spin resonance, in incubation mixtures
containing puri¢ed neuronal NO synthase or P450 reductase
[15]. Both enzymes are present in vascular endothelial and/or
smooth muscle cells. These data are consistent with another
study showing that a variety of novel quinone compounds
potently inhibit endothelial NO synthase by interacting with
the reductase domain of this enzyme [16]. Other investigators
were able to demonstrate superoxide generation from
LY83583 mediated by quinone oxidoreductase [17].
Unexpectedly, we did not observe any e¡ect of DETC on
superoxide production in rat aorta, although inhibition of
SOD and trapping of NO should result in an increase of
vascular superoxide. It was indeed demonstrated that DETC
can slightly increase the lucigenin chemiluminescence signal in
atherosclerotic rabbit aorta [6,7]. This small di¡erence to our
results might be explained by species di¡erences. There are
multiple sources of vascular superoxide in normal arteries
such as NADPH oxidase, cyclooxygenase, XO, myeloperoxi-
dase and non-enzymatic generation by the transfer of elec-
trons from coenzyme Q to molecular oxygen during adenosine
triphosphate (ATP) synthesis in mitochondria [1,18,19]. It is
Fig. 2. E¡ect of 10 mM DETC on superoxide production by the X/
XO system. A: Production of superoxide during incubation of XO
with increasing concentrations of xanthine (0.1^2.4 WM). B: Produc-
tion of superoxide during incubation of XO with increasing concen-
trations of xanthine (0.1^2.4 WM) in the presence of 10 mM DETC.
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quite possible that the contribution of each of these sources to
the total vascular superoxide production varies among di¡er-
ent species and tissues. In addition, DETC-induced inhibition
of superoxide production by XO in rat aorta might counter-
balance its inhibitory e¡ect on SOD so that the net e¡ect is no
change in vascular superoxide production.
This net e¡ect on superoxide production is consistent with
the ¢nding that DETC had no e¡ect on the expression and
activity of vascular sGC. Previous investigations have shown
a negative feedback loop between sGC activity and expression
in isolated smooth muscle cells [20]. These results have been
con¢rmed and extended to the e¡ects of superoxide and per-
oxynitrite on this feedback loop in isolated vessels and in vivo
by several investigations in our lab [10,11]. These oxygen de-
rived radicals inactivate sGC and initiate its expression. Fur-
thermore, not only increased superoxide but also pathologic
alterations associated with an increase of vascular bioavail-
ability of reactive oxygen species such as atherosclerosis in-
hibit the catalytic activity of vascular sGC and markedly in-
crease its expression [10]. Thus, the activity and expression of
vascular sGC appear to be a sensitive biomarker for vascular
oxidative stress.
In summary, we found that the SOD inhibitor DETC had
no e¡ect on basal vascular superoxide bioavailability in rat
aorta, possibly because DETC inhibits both vascular super-
oxide generation by blocking the catalytic activity of oxidore-
ductase enzymes such as XO and those reducing LY83583 in
rat aorta and vascular superoxide degradation by inhibition of
SOD.
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